Annual Long Term Debt
$45.24 M
-$171.00 K-0.38%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual long term debt is $45.24 million, with the most recent change of -$171.00 thousand (-0.38%) on December 31, 2023.
- During the last 3 years, TBPH annual long term debt has fallen by -$601.82 million (-93.01%).
- TBPH annual long term debt is now -93.06% below its all-time high of $652.08 million, reached on December 31, 2021.
Performance
TBPH Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$40.78 M
-$1.66 M-3.90%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly long term debt is $40.78 million, with the most recent change of -$1.66 million (-3.90%) on September 30, 2024.
- Over the past year, TBPH quarterly long term debt has dropped by -$333.00 thousand (-0.81%).
- TBPH quarterly long term debt is now -93.96% below its all-time high of $675.34 million, reached on June 30, 2022.
Performance
TBPH Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TBPH Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.4% | -0.8% |
| 3 y3 years | -93.0% | -93.8% |
| 5 y5 years | -90.0% | -93.7% |
TBPH Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.1% | at low | -94.0% | at low |
| 5 y | 5-year | -93.1% | at low | -94.0% | at low |
| alltime | all time | -93.1% | at low | -94.0% | at low |
Theravance Biopharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $40.78 M(-3.9%) |
| Jun 2024 | - | $42.44 M(-3.2%) |
| Mar 2024 | - | $43.84 M(-3.1%) |
| Dec 2023 | $45.24 M(-0.4%) | $45.24 M(+10.0%) |
| Sep 2023 | - | $41.12 M(-3.3%) |
| Jun 2023 | - | $42.52 M(-2.8%) |
| Mar 2023 | - | $43.76 M(-3.6%) |
| Dec 2022 | $45.41 M(-93.0%) | $45.41 M(-11.6%) |
| Sep 2022 | - | $51.38 M(-92.4%) |
| Jun 2022 | - | $675.34 M(+2.3%) |
| Mar 2022 | - | $659.88 M(+1.2%) |
| Dec 2021 | $652.08 M(+0.8%) | $652.08 M(-0.9%) |
| Sep 2021 | - | $657.69 M(-0.4%) |
| Jun 2021 | - | $660.34 M(+0.1%) |
| Mar 2021 | - | $659.44 M(+1.9%) |
| Dec 2020 | $647.06 M | $647.06 M(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $659.00 M(+1.5%) |
| Jun 2020 | - | $649.32 M(+0.3%) |
| Mar 2020 | - | $647.21 M(+31.3%) |
| Dec 2019 | $492.92 M(+8.5%) | $492.92 M(-0.7%) |
| Sep 2019 | - | $496.25 M(+0.9%) |
| Jun 2019 | - | $491.63 M(-0.7%) |
| Mar 2019 | - | $494.98 M(+8.9%) |
| Dec 2018 | $454.35 M(+103.1%) | $454.35 M(+102.3%) |
| Sep 2018 | - | $224.55 M(+0.1%) |
| Jun 2018 | - | $224.28 M(+0.1%) |
| Mar 2018 | - | $224.01 M(+0.1%) |
| Dec 2017 | $223.75 M(+0.5%) | $223.75 M(+0.1%) |
| Sep 2017 | - | $223.48 M(+0.1%) |
| Jun 2017 | - | $223.21 M(+0.1%) |
| Mar 2017 | - | $222.94 M(+0.1%) |
| Dec 2016 | $222.68 M | $222.68 M |
FAQ
- What is Theravance Biopharma annual long term debt?
- What is the all time high annual long term debt for Theravance Biopharma?
- What is Theravance Biopharma annual long term debt year-on-year change?
- What is Theravance Biopharma quarterly long term debt?
- What is the all time high quarterly long term debt for Theravance Biopharma?
- What is Theravance Biopharma quarterly long term debt year-on-year change?
What is Theravance Biopharma annual long term debt?
The current annual long term debt of TBPH is $45.24 M
What is the all time high annual long term debt for Theravance Biopharma?
Theravance Biopharma all-time high annual long term debt is $652.08 M
What is Theravance Biopharma annual long term debt year-on-year change?
Over the past year, TBPH annual long term debt has changed by -$171.00 K (-0.38%)
What is Theravance Biopharma quarterly long term debt?
The current quarterly long term debt of TBPH is $40.78 M
What is the all time high quarterly long term debt for Theravance Biopharma?
Theravance Biopharma all-time high quarterly long term debt is $675.34 M
What is Theravance Biopharma quarterly long term debt year-on-year change?
Over the past year, TBPH quarterly long term debt has changed by -$333.00 K (-0.81%)